Ginkgo Bioworks Investor

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.


Investors

Investor Type: Private Equity Funds
Founded Date: 2008-01-01
Employee Number: 501-1000
Number Of Exists: 1
Headquarters: Boston
Funding Stage: IPO
Funding Total Value: 1575403063
Founders: Austin Che,Barry Canton,Jason Kelly,Reshma Shetty,Thomas Knight
Phone Number: +1 877 422 5362
Stock Symbol: DNA
City: Boston
Region: Massachusetts
Country: United States
Number Of Investments: 1